Replimune Group, Inc. (REPL) › Cash & EquivalentsReplimune Group, Inc. (REPL) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2018: $17.58M2019: $25.70M2020: $59.50M2021: $182.52M2022: $105.95M2023: $146.59M2024: $74.46M2025: $111.12M$111.12M2018Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$111.12M+49.2%2024$74.46M-49.2%2023$146.59M+38.4%2022$105.95M-42.0%2021$182.52M+206.8%2020$59.50M+131.5%2019$25.70M+46.2%2018$17.58M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share